EU approves Mylan purchase of Abbot generics, subject to conditions

BRUSSELS, Jan 28 (Reuters) - The European Commission approved on Wednesday the acquisition of Abbot Laboratories' non-U.S. Developed Markets Specialty and Branded Generics Business (Abbott EPD-DM) by the U.S. based producer of generic pharmaceuticals Mylan Inc, subject to conditions.